Xcout Intel
Sethera Therapeutics, Inc
Sethera Therapeutics, Inc. is a biotechnology company that features a polymacrocyclic peptide platform for therapeutic discovery and development. The company is headquartered in Salt Lake City, Utah.
Subscribe to see Sethera Therapeutics, Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Sethera Therapeutics, Inc at a glance
Sethera Therapeutics, Inc is a company headquartered in United States. Its most recent funding round raised $1.9M in October 2024. Xcout tracks 9 named people at Sethera Therapeutics, Inc, including Karsten Eastman (CEO).
Sethera Therapeutics, Inc leadership
- Karsten EastmanCEO
- Vahe BandarianCSO and President
- Dr. Lei ShiDirector of Protein Design and Enzyme Engineering
- Cynthia TsaiExecutive Officer
- Dr. Roberto SalatinoLead Molecular Biology Engineer
- Karsten EastmanExecutive Officer
3 more named people on record for Sethera Therapeutics, Inc, with roles, board committees and tenure — see the full roster →
Sethera Therapeutics, Inc funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Sethera Therapeutics, Inc competitors
A few of Sethera Therapeutics, Inc's closest competitors — see the full list of competitors and alternatives →
Carterra, Inc. is based in Salt Lake City, Utah, and specializes in high-throughput antibody screening and characterization platforms for life sciences research and drug discovery.
Seek Labs, Inc. is a healthcare innovations and therapeutics company headquartered in Salt Lake City, Utah, focusing on CRISPR therapeutics and AI molecular diagnostics.
Curza, Inc., based in Salt Lake City, Utah, is a life sciences company developing a pipeline of next-generation therapeutics. The company works to address critical global health challenges, such as the antimicrobial resistance (AMR) crisis.
ePurines, Inc. is a drug development company focused on innovative purinergic-based therapies for obesity, metabolic syndrome, and renal and liver diseases. The company is headquartered in Salt Lake City, Utah.
PolarityTE, Inc. is a biotechnology company headquartered in Salt Lake City, Utah. The company develops regenerative tissue products and advanced medical solutions for the fields of regenerative medicine and tissue repair.
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
Get Sethera Therapeutics, Inc's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Sethera Therapeutics, Inc in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access